Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 17;108(8):e542–e549. doi: 10.1210/clinem/dgad086

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

PMC Copyright notice

Figure 2. — Changes in lipids and apolipoproteins subspecies in the VLDL fraction from baseline to 2 years according to tertiles of blood regional DNA methylation level at CPT1A in low- and high-fat diet group. Models were adjusted for age, sex, use of lipid-lowering medication, baseline body mass index, baseline values of the respective outcomes, and concurrent weight loss. Panel A: Triglycerides in VLDL with apoC-III; B: Cholesterol in VLDL with apoC-III; C: apoB in VLDL with apoC-III; D: apoE in VLDL with apoC-III; E: Triglycerides in VLDL without apoC-III; F: Cholesterol in VLDL without apoC-III; G: apoB in VLDL without apoC-III; H: apoE in VLDL without apoC-III. Sample size for lipids and apolipoproteins subspecies in low-fat group: T1, n = 40; T2, n = 48; T3, n = 44 (except for TG in VLDL with apoC-III, n = 43); high-fat group: T1, n = 53; T2, n = 54 (except for apoB in VLDL with apoC-III, n = 53); T3, n = 44.